Related Experiment Video
Updated: Sep 18, 2025

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Boarding battles: Pharmacist perils in the land of limbo
Jennifer Koehl1, Marc McDowell2, Haley Fox3
1Eli Lilly, Indianapolis, IN, USA.
Insights
Emergency department (ED) boarding is a critical issue impacting patient care and staff. Clinical pharmacists specializing in emergency medicine can implement interventions to improve care for boarding patients within current constraints.
Area of Science:
- Health Services Research
- Pharmacy Practice
- Emergency Medicine
Background:
- Emergency departments (EDs) face persistent overcrowding, escalating into a crisis of ED boarding.
- ED boarding leads to ambulance diversions, delayed care, and patients leaving without treatment.
- Consequences include medication errors, delirium, increased morbidity and mortality, and higher healthcare costs.
Purpose of the Study:
- To address the challenges of ED boarding and its impact on patient care and outcomes.
- To highlight the role of clinical pharmacists in mitigating ED boarding issues.
- To detail interventions for improving care for boarding patients.
Main Methods:
- Focus on interventions by clinical pharmacists, specifically emergency medicine pharmacists (EMPs).
- Utilizing pharmacotherapy monitoring and management.
- Leveraging electronic medical records and automated dispensing cabinets.
Main Results:
- EMPs can provide continuous pharmacotherapy monitoring and management.
- EMPs support smoother transitions of care for boarding patients.
- EMPs can enhance electronic medical records and optimize automated dispensing cabinets.
Conclusions:
- Clinical pharmacists, especially EMPs, are vital in addressing ED boarding challenges.
- EMPs offer tangible interventions to improve care for boarding patients.
- While long-term solutions require systemic reform, current workflows can be optimized by EMPs.
Purpose:
Emergency departments (EDs) across the country have grappled with overcrowded conditions for decades, which has only intensified in recent years, leading to the current crisis of ED boarding. The magnitude of boarding in the ED today is an unprecedented challenge faced by hospitals across North America and results in ambulance diversions, complications due to delays in care, and unacceptable numbers of individuals leaving without being seen by a provider. Boarding has significant immediate and downstream effects, including delayed care, medication errors, delirium, higher rates of morbidity and in-hospital mortality, and greater healthcare costs. As expected, ED boarding has also led to burnout and dissatisfaction among members of the medical team due to increased workload, patient safety concerns, lack of knowledge, resources, and/or training, and poor communication.
Summary:
Clinical pharmacists, particularly those specializing in emergency medicine, are well positioned to address the multifaceted challenges of ED boarding. Emergency medicine pharmacists (EMPs) play a pivotal role in mitigating many challenges of ED boarding by providing tangible interventions, including continuous pharmacotherapy monitoring and management, supporting smooth transitions of care, enhancing electronic medical records, and fully leveraging automated dispensing cabinets. This article details how EMPs can optimize these elements of care for boarding patients with commonly available resources.
Conclusion:
Despite the adverse impact ED boarding has on patient outcomes and quality of care, solutions remain scarce and long-term fixes likely require large-scale health-system reformation. Until then, we must institute protocols and workflows to improve the care of boarding patients within existing patient care constraints.
More Related Videos
Related Concept Videos
Biopharmaceutics and Pharmacokinetics: Overview
Drug Control Governance: Regulatory Bodies and Their Impact
Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
Clearance Models: Compartment Models
Physiological Barriers
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
Hepatic Drug Clearance: Role of Transporters

